NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Intel also Approaches TSMC over Potential Investment and Partnership

Intel CEO Lip-Bu Tan is seeking partnerships with Apple and TSMC for investments or manufacturing, meeting with Tim Cook and C. C. Wei.

Intel also Approaches TSMC over Potential Investment and Partnership
“San Jose / CA / USA - Taiwan Semiconductor Manufacturing Company (TSMC) headquarters in Silicon Valley” by 李 季霖, CC BY-SA 2.0
Already have an account? Sign in.
Featured/ 09/25/2025 · 3:35 PM
INTC
/ Don't stop with just one post.

Related↓

Intel May Manufacture Apple's iPhone Chips Starting in 2028
Featured/ 12/05/2025 · 3:38 PM

Intel May Manufacture Apple's iPhone Chips Starting in 2028

Intel could start producing non-Pro iPhone chips by 2028 using its 14A process, marking a major shift in Apple's manufacturing strategy while maintaining in-house chip design.

/ Subscriber only
Intel Scraps Plans to Sell Networking Division Stake
Featured/ 12/04/2025 · 2:24 PM

Intel Scraps Plans to Sell Networking Division Stake

Intel reverses course on spinning off NEX networking unit, choosing to keep it in-house for better integration with AI and data center offerings.

/ Subscriber only
Intel Stock Surges 7% on Apple Chip Manufacturing Deal
Featured/ 11/28/2025 · 11:32 AM

Intel Stock Surges 7% on Apple Chip Manufacturing Deal

Intel shares jump over 7% after analyst reports Apple may use Intel's foundries for M-series processors starting 2027, marking major win for chip giant's manufacturing business.

/ Subscriber only
/ Read more

Feed↓

Google Ordered to Renegotiate Default Search & AI Deals Every Year
Featured/ 12/08/2025 · 12:46 PM

Google Ordered to Renegotiate Default Search & AI Deals Every Year

A U.S. judge ruled that Google must limit default search and AI app contracts with Apple, Samsung, and other device makers to one year, opening the door for more competition in search and generative AI.

/ Subscriber only
Encouraging Results for Bexobrutideg in Difficult-to-Treat Blood Cancer
12/08/2025 · 12:22 PM

Encouraging Results for Bexobrutideg in Difficult-to-Treat Blood Cancer

Nurix Therapeutics presented positive Phase 1 data for its BTK degrader, bexobrutideg (NX-5948), showing high response rates and favorable safety in heavily pre-treated Waldenström Macroglobulinemia patients.

/ Subscriber only
Wave Life Sciences' Obesity Drug Shows Promising Fat Loss Without Muscle Decline
Featured/ 12/08/2025 · 12:08 PM

Wave Life Sciences' Obesity Drug Shows Promising Fat Loss Without Muscle Decline

Wave Life Sciences' WVE-007 demonstrates 9.4% visceral fat reduction with muscle preservation in Phase 1 trial, earning positive analyst ratings and buy recommendations.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe